October 10, 2026
Microplastics and Marine Supplements: What We Know
A 35-product survey found microplastics in every omega-3 oil, with capsule oil carrying about five times more than raw oil. What that does and does not mean for you.
Research, insights, and practical advice for healthy aging through nutrition.
October 10, 2026
A 35-product survey found microplastics in every omega-3 oil, with capsule oil carrying about five times more than raw oil. What that does and does not mean for you.
October 9, 2026
The average adult in the UK Biobank sits at about 5.6%. The proposed target is 8% or above. Here is what the Omega-3 Index measures, what the data behind that target can and cannot tell you, and what shifts your own result.
October 6, 2026
A landmark 535-patient trial found high-dose fish oil no better than an olive oil placebo for dry eye disease. The pooled data since then complicates that verdict, and the fraction that seems to matter most is not the one DHA-led products lead with.
September 21, 2026
Blink rate falls by two-thirds at a screen. The largest omega-3 trial found nothing; the screen-worker trials found a great deal. Here is how to read that.
September 20, 2026
Fifteen randomised trials, 383 adults, and a fasting glucose shift of 0.04 mmol/L. One 25-person trial found something real in muscle. Here is why the two results do not contradict each other — and what moves the number instead.
September 19, 2026
Every published NMN pharmacokinetic study was run after an overnight fast. Not one has tested a fed dose against a fasted one. That gap is the whole answer.
September 18, 2026
Eight men had 750 mg of NAD+ dripped straight into a vein over six hours. For the first two hours, none of it appeared in their blood. The molecule is too big and too charged to go anywhere intact, and that is before the gut gets involved.
September 17, 2026
Two weeks of low stepping cost ten healthy men 17% of their insulin sensitivity. The enzyme that recycles your NAD+ is set by movement, not by capsules. Here is what NMN can and cannot do about a desk.
September 10, 2026
Across 116 adults randomised to a 16:8 window or three meals a day, the 12-week difference in weight was 0.26 kg. The interesting result is not the scale. It is what the DXA scans showed.
September 9, 2026
A trial of 20 people per arm has about a 16% chance of detecting a real, modest effect. It has a much better chance of producing a headline. Here is what sample size does to a result, and the four checks that tell you whether a study is worth your attention.
September 8, 2026
A meta-analysis of 13 trials in 1,126 people found CoQ10 cut fatigue scores by about a third of a standard deviation. The pooled NMN evidence on physical performance is smaller, shorter and flatter. Here is what each one has actually shown.
September 7, 2026
Across 233,455 adults, apoB carried 43% more cardiovascular risk per standard deviation. LDL-C carried 25%. Where the two numbers disagree, who they mislead, and how to get apoB measured in the UK.
September 6, 2026
Eighty-nine per cent of 57 sports supplements did not contain what their labels declared. UK law already asks a lot of a supplement seller. Here is what compliance looks like from the outside, and the checks that separate a real operation from a drop-shipper.
September 5, 2026
Seventy per cent of an oral dose is absorbed, and almost none of it survives the first pass. Piperine is the standard answer. Here is what the trials actually measured.
September 4, 2026
Across 1,894 commercial fish oils, mean mercury came in at 0.0005 mg/kg — one two-hundredth of the legal ceiling. The quality problem in this category is real, but it is not the metals.
September 3, 2026
The authorised claim sits at 250 mg a day. The trials that moved muscle, triglycerides or blood levels used four to fourteen times that. Your body weight, the chemical form and the meal you take it with all change the number.
September 2, 2026
The largest randomised trial on this question gave 18,353 adults omega-3 for five years and came back flat. The small signal that does exist belongs to EPA, at a dose most capsules never reach.
September 1, 2026
The biggest trial ever run in adults over 50 gave 840 mg a day for five years and missed its primary endpoint. The useful effects sit elsewhere — and at higher doses than most labels carry.
August 30, 2026
Take 250 mg of NMN after 6pm for twelve weeks and your sleep score falls 1.5 points. Take a placebo after 6pm and it falls 1.6. That is the whole timing literature, and it is worth reading properly.
August 29, 2026
Both molecules end up as the same thing inside the cell. The argument is about how they get in, and whether any of it reaches the tissue you care about. Here is what the human data shows.
August 28, 2026
One six-week trial in 48 amateur runners raised power at the ventilatory thresholds and left VO2 max untouched. Meanwhile, twelve weeks of training raised the NAD+ salvage enzyme by 28% on its own. Here is how a rider should read that.
August 27, 2026
Shift ten adults twelve hours out of phase and their insulin rises 22%. The mouse work says the body clock builds NAD+ on a schedule. The human evidence is thinner, and more useful, than either side admits.
August 26, 2026
A p-value of 0.04 does not mean a 96% chance the supplement works. It answers a narrower question than almost anyone selling you something wants to admit. Here is what the number measures, what it hides, and the six questions worth asking instead.
August 25, 2026
The average tolerable NAD+ infusion ran three hours and three minutes. Saline took 85. Here is what the drip delivers, what a capsule delivers, and why neither has cleared the outcome bar yet.
August 24, 2026
A three-fold higher CRP came with 37% more coronary events across 160,309 adults. Then the genetics arrived and complicated it. What the marker is worth, how noisy it is, and what actually shifts it.
August 22, 2026
The statute gives the risk assessor nine months. Across 292 dossiers, the average run from submission to published opinion was 935 days. Here is what the GB novel foods process does, and where NMN and algal DHA sit inside it.
August 21, 2026
Only seven of 20 resveratrol supplements named the isomer on the label. That word covers two molecules with different stability, different absorption and, on recent evidence, opposite effects on one repair pathway.
August 20, 2026
Vegan DHA does not come from seaweed or a pond. It is fermented in the dark, in stainless steel, on sugar. Here is the chain from seed flask to softgel, and the three numbers that tell you whether a given bottle was made well.
August 18, 2026
Nine trials have given people pure EPA or pure DHA and compared them directly. DHA wins on blood pressure and triglycerides, loses on LDL, and EPA holds the only large outcome trial. The gap matters more than the label suggests.
August 17, 2026
Two trials in over 5,000 adults found no cognitive effect at all. Three smaller ones found a memory benefit. The difference is not dose — it is who was enrolled, and that changes what the evidence is worth to you.
August 8, 2026
The number most likely to turn up on your next blood panel. What it measures, where the UK lines are drawn, the four things that make it lie, and what the supplement trials actually found.
July 25, 2026
Stimulants borrow energy. NAD+ makes it. A deep dive into lipolysis, the carnitine shuttle, beta-oxidation, sirtuins and mitochondrial biogenesis.
March 29, 2026
How this ancient fatty acid shaped human evolution, why modern diets are dangerously deficient, and what the science says about DHA for brain, heart and eye health.
March 26, 2026
Peer-reviewed research from Harvard, Washington University, and Karolinska Institutet reveals how NMN restores retinal NAD+ levels and protects against age-related vision loss.
March 26, 2026
Discover why fat burning gets harder with age and how NMN and Resveratrol restore your body's lipolytic pathways by boosting NAD+ and activating SIRT1.
March 15, 2026
Discover how Nicotinamide Mononucleotide works as a direct precursor to NAD+, why your levels decline with age, and what the latest research says about supplementation.
March 10, 2026
Learn why going straight to the source means purer DHA without the heavy metals, PCBs, and contaminants found in traditional fish oil supplements.
March 5, 2026
Simple, evidence-based nutrition changes that support your body as you age. From targeted supplementation to dietary foundations that matter most.
April 4, 2026
How much NMN should you take per day? Our complete dosage guide covers amounts by age, optimal timing, food pairing, and what results to expect at each stage.
April 4, 2026
Is NMN safe? We examine the human clinical trial data on NMN side effects, who should avoid it, and what to watch out for when starting supplementation.
April 4, 2026
NMN fuels NAD+ production; Resveratrol activates the sirtuins that use it. Together they create a synergistic effect greater than either compound alone.
April 4, 2026
Yes, NMN is legal to buy in the UK. We explain the novel food framework, the FSA assessment process, and what it means for consumers in 2026.
April 4, 2026
How NMN and Resveratrol support cardiovascular health, energy, muscle preservation, and cognitive performance in men over 50 — backed by clinical evidence.
April 4, 2026
Energy, skin health, hair, and healthy ageing through menopause and beyond — how this science-backed combination supports women's health after 40.
April 4, 2026
A realistic week-by-week guide to NMN results — from the first energy improvements to the deeper cellular health benefits that emerge over months.
April 4, 2026
We cut through the marketing to compare the leading NMN supplements available in the UK on purity, dose, third-party testing, and value for money.
April 4, 2026
Everything you need to know about choosing a high-quality vegan omega-3 supplement in the UK — dosage, DHA vs EPA, algae sources, and what to avoid.
April 4, 2026
Struggling with brain fog? DHA deficiency may be the cause. Learn how algae-derived omega-3 supports memory, focus, and mental clarity — backed by research.
April 4, 2026
A deep dive into NAD+ — the master molecule of cellular energy. Why it drops by 50% by middle age, and the most effective strategies to restore it.
April 4, 2026
From NMN and Resveratrol to omega-3 and beyond — an evidence-based overview of the longevity supplements with the strongest scientific support in 2026.